Stay updated on MGD013 and Brivanib in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.

Latest updates to the MGD013 and Brivanib in Liver Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision (v3.5.0) was added and the previous revision (v3.4.3) was removed from the study record history.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a new revision entry 'Revision: v3.4.3' and removed 'Revision: v3.4.2' from the history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page history shows a new revision entry (v3.4.2) replacing the previous revision (v3.4.1). This update is limited to release notes and does not alter study data or visible content on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded a new revision entry v3.4.1 and removed v3.4.0 from the history, reflecting a minor update to the page's version history.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 from the record history.SummaryDifference0.1%

- Check68 days agoChange DetectedUI enhancements include a glossary toggle, color-coded highlights for additions (green) and deletions (red), and an updated footer showing Revision: v3.4.0; the 'No FEAR Act Data' entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to MGD013 and Brivanib in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.